Literature DB >> 8811675

Supratentorial glioblastoma: neuroradiological findings and survival after surgery and radiotherapy.

A Pierallini1, M Bonamini, M F Osti, P Pantano, F Palmeggiani, A Santoro, R Maurizi Enrici, L Bozzao.   

Abstract

Few studies have attempted to correlate neuroimaging with outcome in patients with glioblastoma. Our aim was to evaluate the relationship between neuroradiological findings and survival in these patients. We studied 18 consecutive patients with glioblastoma who had undergone surgery and radiotherapy. We assessed the following features, using preoperative CT and/or MRI: tumour size, extent of necrotic area within the mass, extent of perifocal oedema and contrast enhancement. The mean survival was 14.2 +/- 5 months (range 6-22). The extent of radiological evidence of necrosis within the mass correlated significantly with survival time, whereas tumour size, perifocal oedema and contrast enhancement did not.

Entities:  

Mesh:

Year:  1996        PMID: 8811675     DOI: 10.1007/bf02278114

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  18 in total

1.  Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme.

Authors:  H G Höllerhage; M Zumkeller; M Becker; H Dietz
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection.

Authors:  I Ciric; M Ammirati; N Vick; M Mikhael
Journal:  Neurosurgery       Date:  1987-07       Impact factor: 4.654

3.  Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.

Authors:  M C Chamberlain; J A Murovic; V A Levin
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

4.  Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

Authors:  B C Devaux; J R O'Fallon; P J Kelly
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

5.  A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.

Authors:  W J Curran; C B Scott; J S Nelson; A S Weinstein; T L Phillips; K Murray; A J Fischbach; D Yakar; J G Schwade; W D Powlis
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

6.  Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.

Authors:  F W Kreth; P C Warnke; R Scheremet; C B Ostertag
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

7.  Correlates of survival and the Daumas-Duport grading system for astrocytomas.

Authors:  T S Kim; A L Halliday; E T Hedley-Whyte; K Convery
Journal:  J Neurosurg       Date:  1991-01       Impact factor: 5.115

8.  A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984.

Authors:  M Kallio; R Sankila; J Jääskeläinen; S Karjalainen; T Hakulinen
Journal:  Cancer       Date:  1991-09-15       Impact factor: 6.860

9.  Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. EORTC Brain Tumor Group.

Authors: 
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

10.  The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas.

Authors:  R E Peschel; L Wilson; B Haffty; D Papadopoulos; K Rosenzweig; M Feltes
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-06-15       Impact factor: 7.038

View more
  6 in total

1.  Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging.

Authors:  M Ricci; P Pantano; A Pierallini; D Di Stefano; A Santoro; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma.

Authors:  K Lote; T Egeland; B Hager; K Skullerud; H Hirschberg
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

Review 3.  Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.

Authors:  Christian Henker; Thomas Kriesen; Änne Glass; Björn Schneider; Jürgen Piek
Journal:  J Neurooncol       Date:  2017-07-28       Impact factor: 4.130

4.  MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.

Authors:  J Zhou; M V Reddy; B K J Wilson; D A Blair; A Taha; C M Frampton; R A Eiholzer; P Y C Gan; F Ziad; Z Thotathil; S Kirs; N A Hung; J A Royds; T L Slatter
Journal:  AJNR Am J Neuroradiol       Date:  2017-11-30       Impact factor: 3.825

5.  Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma.

Authors:  Chen-Xing Wu; Guo-Shi Lin; Zhi-Xiong Lin; Jian-Dong Zhang; Shui-Yuan Liu; Chang-Fu Zhou
Journal:  World J Surg Oncol       Date:  2015-03-11       Impact factor: 2.754

6.  Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma.

Authors:  Chen-Xing Wu; Guo-Shi Lin; Zhi-Xiong Lin; Jian-Dong Zhang; Long Chen; Shui-Yuan Liu; Wen-Long Tang; Xian-Xin Qiu; Chang-Fu Zhou
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.